Liver and intrahepatic bile ducts-nontumor
HHV6 (human herpes virus 6)
Reviewers: Komal Arora, M.D. (see Reviewers page)
Revised: 9 May 2012, last major update May 2012
Copyright: (c) 2004-2012, PathologyOutlines.com, Inc.
● Infections occur in > 95% of humans; primary infection occurs in early childhood as asymptomatic illness or clinically as roseola infantum (exanthum subitum / HHV6B), leads to subclinical viral persistence and latency; rarely hepatitis, meningoencephalitis or febrile convulsions
● Reactivation of latent HHV6 is common after liver transplantation, possibly induced and facilitated by allograft rejection and immunosuppressive therapy (World J Gastroenterol 2009;15:2561)
● High intrahepatic HHV-6 virus loads are associated with decreased graft survival after diagnosis of graft hepatitis (J Hepatol 2012;56:1)
● 8 month old boy with fulminant hepatic failure due to HHV-6 infection (Hum Pathol 2001;32:887)
● 18 year old immunocompetent woman presenting with sever jaundice and liver dysfunction (Cases J 2008;1:110)
● Panlobular microvesicular steatosis in glycogen-depleted hepatocytes resembling Reye’s syndrome, eosinophilic central hepatocytes, with some nuclear disappearance
● Minimal inflammation, no changes in portal areas
Cervical lymph node and liver
Electron microscopy images
Cervical lymph node
End of Liver and intrahepatic bile ducts-nontumor > Viral hepatitis > HHV6 (human herpes virus 6)
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).